New Medicines, Novel Insights: Accelerating development of cell and gene therapies

Cell and gene therapies offer extraordinary hope to patients with advanced cancers and genetic diseases but pose unprecedented challenges for sponsors. In this report, Parexel experts share insights that can bring these complex treatments to market faster and more efficiently.

Explore the report

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Article

Bringing clinical trials to patients with the decentralized model

Jan 8, 2021

Blog

Decentralized Trials: Considerations for Building a New Patient-Centric Model

May 13, 2021

Article

Three ways to work with the FDA for better patient-focused trials

Jul 29, 2021

Video

How to transition existing trials under EU-CTR

Feb 1, 2023

Article

Decentralized trial tools and technologies are here to stay: A regulatory perspective

Jul 23, 2021

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021

Blog

A patient-centric approach to managing clinical trial complexity

Jul 13, 2021

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Blog

Including patients in DCT design

Sep 13, 2022

Playbook

Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023